Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-09 Purchase | 2023-08-10 09:03 am | IO Biotech Inc. | IOBT | Vivo Capital IX LLC Vivo Capital Fund IX L.P. Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner | 3,157,894 | $1.9 | $5,999,999 | 9,331,333 (Indirect) | View |
| 2022-05-05 Sale | 2022-05-05 6:55 pm | Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner | 5,374 | $12.25 | $65,832 | 2,469,001 (Indirect) | View |
| 2022-05-02 Sale | 2022-05-04 8:01 pm | Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner | 512,956 | $13.39 | $6,866,311 | 2,474,375 (Indirect) | View |
| 2022-01-31 Purchase | 2022-01-31 9:30 pm | Sierra Oncology Inc. | SRRA | Vivo Opportunity LLC Vivo Opportunity Fund L.P. Vivo Capital IX LLC Vivo Capital Fund IX L.P. VIVO VENTURES VII LLC Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. 10% Owner | 800,000 | $27 | $21,600,000 | 3,329,512 (Indirect) | View |
| 2021-11-09 Purchase | 2021-11-12 4:16 pm | IO Biotech Inc. | IOBT | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner | 650,000 | $14 | $9,100,000 | 3,015,545 (Direct) | View |
| 2021-06-23 Sale | 2021-06-25 9:30 pm | Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner | 55,684 | $29.79 | $1,658,842 | 2,987,331 (Indirect) | View |
| 2021-06-21 Sale | 2021-06-25 8:51 pm | Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner | 201,620 | $29.05 | $5,856,114 | 3,043,015 (Indirect) | View |
| 2021-04-14 Sale | 2021-04-16 9:07 pm | Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner | 400 | $30.37 | $12,148 | 3,244,635 (Indirect) | View |
| 2021-03-23 Purchase | 2021-03-25 5:32 pm | Instil Bio Inc. | TIL | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner | 300,000 | $20 | $6,000,000 | 12,486,787 (Direct) | View |
| 2020-10-20 Purchase | 2020-10-20 7:58 pm | Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner | 250,000 | $16 | $4,000,000 | 3,245,035 (Direct) | View |
| 2020-07-21 Purchase | 2020-07-21 8:25 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Vivo Capital IX LLC Vivo Capital Fund IX L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner | 975,000 | $19 | $18,525,000 | 185,526 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion